| Caitlyn Sciarrotta, RN | |
|
1306 River Ave, Lakewood, NJ 08701-5614 | |
| (866) 387-8100 | |
| Not Available |
| Full Name | Caitlyn Sciarrotta |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1306 River Ave, Lakewood, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013414242 | NPI | - | NPPES |
| 26NR15554000 | Other | NJ | NJ LICENSING BOARD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR15554000 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Caitlyn Sciarrotta, RN 6502 Lower York Rd, First Floor, New Hope, PA 18938 Ph: (609) 575-4459 | Caitlyn Sciarrotta, RN 1306 River Ave, Lakewood, NJ 08701-5614 Ph: (866) 387-8100 |
News Archive
Researchers have found that SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment. Therefore, strategies such as focusing on limiting the production of IFN, rather than its function, could restrict the mechanism of SARS-CoV-2 that increases its viral load with delayed or absent symptoms.
Researchers have given new insights into why people would choose to donate Covid-19 plasma after recovering from the virus, which will be used to support the recruitment of convalescent plasma donors to help treat current Covid-19 patients and support ongoing trials.
With the start of the school year just around the corner, it is easy to overlook one of the most important things on any back-to-school checklist -; making sure your child is vaccinated. Vaccinations protect children from serious diseases, ultimately protecting families, schools and communities by way of safe and effective immunizations.
Bristol-Myers Squibb Company today reported results for the third quarter of 2010. Highlights in the quarter included: the presentation of new data on investigational compounds in the diabetes and cardiovascular disease franchises at major medical meetings; the completion of important regulatory milestones in the oncology, diabetes and immunoscience franchises; the acquisition of ZymoGenetics; and double-digit EPS growth. The company also confirmed guidance for 2010.
Protalix Biotherapeutics, Inc. (NYSE-Amex: PLX), announced the completion of its pivotal Phase III trial for prGCD, the Company's proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease. The trial enrolled a total of 31 patients across Europe, North America, South America, Israel and South Africa. No serious adverse events were reported in this trial.
› Verified 9 days ago
Mrs. Tirtzah Kaluszyner, FNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 484 Somerset Ave, Lakewood, NJ 08701 Phone: 347-525-8534 | |
Yuliya Bilan Yu, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 2nd St, Lakewood, NJ 08701 Phone: 732-363-6655 Fax: 732-901-0277 | |
Chana Silver, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Chelsea Ct, Lakewood, NJ 08701 Phone: 732-278-0711 | |
Mrs. Kristy Lynn Defluri, MSN, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: 360 Route 70, Lakewood, NJ 08701 Phone: 732-942-9835 | |
Kate Bianchini, APN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 600 River Ave, Lakewood, NJ 08701 Phone: 732-773-5340 | |
Mrs. Sheva Gluck, CNM Registered Nurse Medicare: Medicare Enrolled Practice Location: 1382 Lanes Mill Rd, Lakewood, NJ 08701 Phone: 732-994-4242 |